Effect of Cytosine Arabinoside and 5-iodo-2'-deoxyuridine on a Cytomegalovirus Infection in Newborn Mice

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1976 Mar 1

PMID 176935

Citations 12

Authors

D K Kelsey

E R Kern

J C Overall Jr

L A Glasgow

Affiliations

Soon will be listed here.

Abstract

Murine cytomegalovirus was inhibited by 0.6 to 1.2 mug of cytosine arabinoside per ml and by 0.3 to 0.6 mug of 5-iodo-2'-deoxyuridine in mouse embryo fibroblast cells. Human cytomegalovirus was inhibited by similar concentrations of the two drugs in WI-38 cells. Intraperitoneal inoculation of suckling mice with 10(4.5) plaque-forming units of murine cytomegalovirus provides a model for disseminated human cytomegalovirus infection in human newborn infants and is characterized by a widespread infection involving the liver, spleen, lung, kidney, and brain with a 70 to 90% mortality in 7 to 9 days. Treatment with 12.5 mg of cytosine arabinoside per kg or 25 mg of 5-iodo-2'-deoxyuridine per kg twice daily for 8 days had no effect on final mortality or the pathogenesis of the infection with the exception of reduced viral titers in the spleen of 5-iodo-2'-deoxyuridine-treated animals. These data indicate that neither cytosine arabinoside nor 5-iodo-2'-deoxyuridine are effective in the treatment of murine cytomegalovirus infections in suckling mice and suggest that they may be of limited value in the treatment of severe cytomegalovirus infections in human neonates.

Citing Articles

Atypical cytomegalovirus retinal disease in pyroptosis-deficient mice with murine acquired immunodeficiency syndrome.

Carter J, Nemeno J, Oh J, Houghton J, Dix R Exp Eye Res. 2021; 209:108651.

PMID: 34097907 PMC: 8595509. DOI: 10.1016/j.exer.2021.108651.

Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.

Alston C, Dix R PLoS One. 2017; 12(2):e0171812.

PMID: 28182772 PMC: 5300177. DOI: 10.1371/journal.pone.0171812.

Activity of trifluorothymidine against cytomegalovirus.

Wingard J, Stuart R, Saral R, BURNS W Antimicrob Agents Chemother. 1981; 20(3):286-90.

PMID: 6272627 PMC: 181689. DOI: 10.1128/AAC.20.3.286.

Efficacy of acyclovir against mouse cytomegalovirus in vivo.

Wingard J, Bender W, Saral R, BURNS W Antimicrob Agents Chemother. 1981; 20(2):275-8.

PMID: 6269490 PMC: 181681. DOI: 10.1128/AAC.20.2.275.

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.

Freitas V, Smee D, Chernow M, Boehme R, Matthews T Antimicrob Agents Chemother. 1985; 28(2):240-5.

PMID: 3010840 PMC: 180226. DOI: 10.1128/AAC.28.2.240.

References

HILDEBRANDT R, Sever J, Margileth A, CALLAGAN D . Cytomegalovirus in the normal pregnant woman. Am J Obstet Gynecol. 1967; 98(8):1125-8. DOI: 10.1016/0002-9378(67)90038-5. View

Buthala D . CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE. Proc Soc Exp Biol Med. 1964; 115:69-77. DOI: 10.3181/00379727-115-28834. View

Stern H, ELEK S . THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON. J Hyg (Lond). 1965; 63:79-87. PMC: 2134629. DOI: 10.1017/s0022172400044983. View

Person D, Sheridan P, Herrmann E . Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine. Infect Immun. 1970; 2(6):815-20. PMC: 416096. DOI: 10.1128/iai.2.6.815-820.1970. View

Osborn J, Walker D . Virulence and attenuation of murine cytomegalovirus. Infect Immun. 1971; 3(2):228-36. PMC: 416136. DOI: 10.1128/iai.3.2.228-236.1971. View

Kern E, Overall Jr J, Glasgow L . Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine. Antimicrob Agents Chemother. 1975; 7(5):587-95. PMC: 429187. DOI: 10.1128/AAC.7.5.587. View

Melish M, Hanshaw J . Congenital cytomegalovirus infection. Developmental progress of infants detected by routine screening. Am J Dis Child. 1973; 126(2):190-4. DOI: 10.1001/archpedi.1973.02110190168011. View

Kanich R, Craighead J . Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipients. Am J Med. 1966; 40(6):874-82. DOI: 10.1016/0002-9343(66)90202-6. View

Osborn J, MEDEARIS Jr D . Suppression of interferon and antibody and multiplication of Newcastle disease virus in cytomegalovirus infected mice. Proc Soc Exp Biol Med. 1967; 124(2):347-53. DOI: 10.3181/00379727-124-31740. View

10.

Osborn J, Blazkovec A, Walker D . Immunosuppression during acute murine cytomegalovirus infection. J Immunol. 1968; 100(4):835-44. View

11.

HILDEBRANDT R, Monif G . Congenital cytomegalovirus infection. Am J Obstet Gynecol. 1969; 105(3):349-53. DOI: 10.1016/0002-9378(69)90262-2. View

12.

Starr J, Bart Jr R, Gold E . Inapparent congenital cytomegalovirus infection. Clinical and epidemiologic characteristics in early infancy. N Engl J Med. 1970; 282(19):1075-8. DOI: 10.1056/NEJM197005072821905. View

13.

WENTWORTH B, French L . Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med. 1970; 135(2):253-8. DOI: 10.3181/00379727-135-35031. View

14.

KRAYBILL E, Sever J, Avery G, MOVASSAGHI N . Experimental use of cytosine arabinoside in congenital cytomegalovirus infection. J Pediatr. 1972; 80(3):485-7. DOI: 10.1016/s0022-3476(72)80514-6. View

15.

McCracken Jr G, Luby J . Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease. J Pediatr. 1972; 80(3):488-93. DOI: 10.1016/s0022-3476(72)80515-8. View

16.

Lang D . Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis. Arch Gesamte Virusforsch. 1972; 37(4):365-77. DOI: 10.1007/BF01241460. View

17.

Sidwell R, Arnett G, SCHABEL Jr F . In vitro effect of a variety of biologically active compounds on human cytomegalovirus. Chemotherapy. 1972; 17(4):259-82. DOI: 10.1159/000220858. View

18.

Emodi G, Sartorius J, Just M, Rohner F, BUHLER U . Virus studies in the treatment of congenital cytomegalovirus infections by cytosine arabinoside. Helv Paediatr Acta. 1972; 27(6):557-64. View

19.

Henson D, Siegel S, FUCCILLO D, Matthew E, Levine A . Cytomegalovirus infections during acute childhood leukemia. J Infect Dis. 1972; 126(5):469-81. DOI: 10.1093/infdis/126.5.469. View

20.

Kern E, Overall Jr J, Glasgow L . Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine. J Infect Dis. 1973; 128(3):290-9. DOI: 10.1093/infdis/128.3.290. View